glp 1 pancreatic cancer risk Frontiers Use of Glucagon-Like Peptide-1 Receptor

Cleve Clin

GLP-1 receptor agonists not only reduce appetite but also reshape food preferences, shedding light on the neural mechanisms underlying compulsive consumption and offering potential therapeutic avenues for metabolic and behavioral disorders

However, whether a protein of such size could infiltrate the bloodbrain barrier to bind GLP-1R and GIPR in the brain, and whether receptors in the brain are important to the therapeutic effect, still need to be elucidated

GLP-1 receptor agonists are medications that mimic this hormone, helping manage conditions like type 2 diabetes , insulin resistance , and obesity